- Trials with a EudraCT protocol (53)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
53 result(s) found for: Inotropes.
Displaying page 1 of 3.
EudraCT Number: 2008-005988-33 | Sponsor Protocol Number: BRD/08/9-N | Start Date*: 2009-01-19 | |||||||||||
Sponsor Name:CHU de Nantes | |||||||||||||
Full Title: Comparaison du test au monoxyde d'azote aux épreuves pharmacologiques vasodiliatatrices et inotropes dans l'évaluation de la réversibilité de l'hypertension artérielle pulmonaire post-capillaire ch... | |||||||||||||
Medical condition: hypertension artérielle pulmonaire | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002701-59 | Sponsor Protocol Number: IIBSP-CAR-2018-71 | Start Date*: 2019-04-12 |
Sponsor Name:Institut de Recerca Hospital de la Santa Creu i Sant Pau | ||
Full Title: Randomized, open and multi-center clinical trial to compare the efficacy and safety of Buckberg vs Del Nido cardioplegia in isolated aortic valve replacement | ||
Medical condition: Myocardial protection | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-003158-10 | Sponsor Protocol Number: GI-CCT372273 | Start Date*: 2014-04-11 | |||||||||||
Sponsor Name:The George Institute for Global Health | |||||||||||||
Full Title: ADRENAL- ADjunctive coRticosteroid trEatment iN criticAlly ilL patients with septic shock. | |||||||||||||
Medical condition: Septic Shock | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DK (Completed) IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-005310-19 | Sponsor Protocol Number: PI-0697-2012 | Start Date*: 2013-06-05 |
Sponsor Name:FUNDACION PARA LA INVESTIGACIÓN BIOSANITARIA DE ANDALUCIA ORIENTAL_ FPA | ||
Full Title: Double-blind randomized clinical trial to evaluate the efficacy and safety of levosimendan as preischemic myocardial conditioner in pediatric cardiac surgery | ||
Medical condition: Children aged 1 month to 14 years in the health area of the province of Granada who will be undergoing heart surgery with a clinical high risk of developing acute heart failure after surgery, treat... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2009-013929-42 | Sponsor Protocol Number: 39588146AHF2001 | Start Date*: 2010-07-08 | |||||||||||
Sponsor Name:Janssen-Cilag International NV | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JNJ-39588146 in Subjects with Heart Failure | |||||||||||||
Medical condition: JNJ-39588146 is being developed for the treatment of heart failure. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-000337-36 | Sponsor Protocol Number: FSJD-GLUCOBR-2010 | Start Date*: 2011-08-30 | |||||||||||
Sponsor Name:FUNDACIÓ SANT JOAN DE DÉU | |||||||||||||
Full Title: IMPACT OF THE ADMINISTRATION OF SYSTEMIC GLUCOCORTICOIDS ON INFLAMMATORY RESPONSE AND CLINICAL EVOLUTION OF PATIENTS DIAGNOSED WITH MODERATE-SEVERE BRONCHIOLITIS | |||||||||||||
Medical condition: Viral bronchiolitis | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-003902-29 | Sponsor Protocol Number: EASI-Child | Start Date*: 2020-04-30 | |||||||||||
Sponsor Name:IRCCS, OSPEDALE PEDIATRICO BAMBINO GESÙ DI ROMA | |||||||||||||
Full Title: Early Administration of Ivabradine in Children with Heart Failure. | |||||||||||||
Medical condition: Acute hearth failure in dilated cardiomyopathy. | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002429-39 | Sponsor Protocol Number: Leodor2017 | Start Date*: 2017-10-27 |
Sponsor Name:Medical University Innsbruck | ||
Full Title: REPETITIVE LEVOSIMENDAN INFUSIONS FOR PATIENTS WITH ADVANCED CHRONIC HEART FAILURE | ||
Medical condition: Advanced chronic heart failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) DE (Completed) HU (Completed) SI (Completed) FI (Completed) DK (Prematurely Ended) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2016-002154-20 | Sponsor Protocol Number: CLCZ696G2301 | Start Date*: 2017-03-28 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A multi-center, randomized, double-blind, active-controlled, parallel-group Phase 3 study to evaluate the efficacy and safety of LCZ696 compared to ramipril on morbidity and mortality in high risk ... | |||||||||||||
Medical condition: Left ventricular dysfunction following an acute myocardial infarction. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PT (Completed) CZ (Completed) GB (GB - no longer in EU/EEA) GR (Completed) AT (Completed) SK (Completed) NL (Completed) ES (Completed) HU (Completed) BE (Completed) DK (Completed) SE (Completed) FI (Completed) BG (Completed) HR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001636-95 | Sponsor Protocol Number: 282110 | Start Date*: 2020-05-20 | |||||||||||
Sponsor Name:University of Manchester | |||||||||||||
Full Title: Subcutaneous and Intravenous anakinra in COVID-19 Infection - Feasibility & Pharmacokinetics/ Pharmacodynamics study | |||||||||||||
Medical condition: Suspected or confirmed SARS-CoV-2 infection (confirmed by RNA-PCR) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002229-27 | Sponsor Protocol Number: TACTIC-E | Start Date*: 2020-06-09 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | ||
Full Title: mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 – Experimental drugs and mechanisms | ||
Medical condition: SARS-Cov-2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002510-23 | Sponsor Protocol Number: SR062014 | Start Date*: 2014-09-17 |
Sponsor Name:University hospitals of Leuven | ||
Full Title: as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: a randomized controlled clinical trial | ||
Medical condition: Xenon anesthesia in children undergoing cardiac catheterization | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000005-23 | Sponsor Protocol Number: Ghreline | Start Date*: 2018-12-12 |
Sponsor Name:University of Twente | ||
Full Title: Ghrelin treatment of comatose patients after cardiac arrest: A clinical trial to promote cerebral recovery | ||
Medical condition: Brain damage after cardiac arrest | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001354-22 | Sponsor Protocol Number: TACTIC-R | Start Date*: 2020-05-06 |
Sponsor Name:Cambridge University Hospitals NHS Foundation Trust | ||
Full Title: Multiarm Therapeutic study in pre-ICU patients admitted with COVID-19 - Repurposed Drugs (TACTIC-R) | ||
Medical condition: COVID-19-related complications | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2009-009657-19 | Sponsor Protocol Number: S201 | Start Date*: 2009-11-04 |
Sponsor Name:Ikaria, Inc. | ||
Full Title: A randomized, double-blind, placebo-controlled, multi-center study of IK-1001 to evaluate safety, population pharmacokinetics and proof-of-concept efficacy for reduction of ischemia-reperfusion med... | ||
Medical condition: It will be conducted in subjects undergoing coronary artery bypass graft (CABG) surgery | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-002258-56 | Sponsor Protocol Number: SD-DXP | Start Date*: 2018-08-27 |
Sponsor Name:University Hospitals Leuven | ||
Full Title: The use of xenon and dexmedetomidine for the prevention of postoperative emergence delirium after anaesthesia for pediatric cardiac catheterization: A randomized, controlled, observer-blinded pilot... | ||
Medical condition: xenon-dexmedetomidine Anesthesia in children undergoing cardiac catheterization | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003858-85 | Sponsor Protocol Number: HFIRONT | Start Date*: 2020-02-24 |
Sponsor Name:Medical University Innsbruck | ||
Full Title: Randomized double-blind explorative controlled clinical trial analyzing the effects of ferric carboxymaltose in patients with iron deficiency and chronic heart failure | ||
Medical condition: This is a randomized double-blind explorative controlled clinical Trial that analyses the effects of 1000mg ferric carboxymaltose in patients with chronic heart failure and iron deficiency. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-002988-16 | Sponsor Protocol Number: MINT-2014-01 | Start Date*: 2015-07-01 | |||||||||||
Sponsor Name:Royal College of Surgeons in Ireland | |||||||||||||
Full Title: The Use of Milrinone in Neonates with Persistent Pulmonary Hypertension of the Newborn: A Randomised Controlled Trial Pilot Study (MINT 1) | |||||||||||||
Medical condition: Persistent Pulmonary Hypertension of the Newborn | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) NL (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004625-24 | Sponsor Protocol Number: AP-recAP-AKI-03-01 | Start Date*: 2020-09-04 | |||||||||||||||||||||
Sponsor Name:AM-Pharma B.V. | |||||||||||||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel Group, Multi-Center Phase 3 Pivotal Trial to Investigate the Efficacy and Safety of Recombinant Human Alkaline Phosphatase for Treat... | |||||||||||||||||||||||
Medical condition: Sepsis-associated acute kidney injury | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: FR (Prematurely Ended) NL (Completed) DK (Prematurely Ended) FI (Completed) DE (Prematurely Ended) GB (GB - no longer in EU/EEA) BE (Completed) IE (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-002774-39 | Sponsor Protocol Number: PDY15079 | Start Date*: 2018-01-23 | |||||||||||
Sponsor Name:SANOFI-AVENTIS RECHERCHE ET DEVELOPPEMENT | |||||||||||||
Full Title: An Exploratory, Randomized, Double-blind, Placebo-controlled, Parallel Arm Trial of the Safety and Pharmacodynamic Activity of Sotagliflozin in Hemodynamically Stable Patients with Worsening Heart ... | |||||||||||||
Medical condition: Cardiac Failure aggravated | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
